1.14.14.17	D335F	mutation in FAD II binding site, nonfunctional enzyme	671379	
1.14.14.17	D335F	random mutagenesis, mutation in the FADII site, inactive mutant	671379	
1.14.14.17	D335P	mutation in FAD II binding site, nonfunctional enzyme	671379	
1.14.14.17	D335P	random mutagenesis, mutation in the FADII site, inactive mutant	671379	
1.14.14.17	D335W	mutation in FAD II binding site, nonfunctional enzyme	671379	
1.14.14.17	D335W	random mutagenesis, mutation in the FADII site, inactive mutant	671379	
1.14.14.17	D407F	site-directed mutagenesis, mutant shows 8% of wild-type activity	657764	
1.14.14.17	E60A	site-directed mutagenesis in the highly conserved motif 1, the E60A variant poorly complements growth of KLN1, and shows reduced activity and about 50fold increased sensitivity to terbinafine and naftifine and 5fold to ketoconazole compared to that in the wild type, and confers temperature-sensitive growth	684491	
1.14.14.17	E60Q	site-directed mutagenesis in the highly conserved motif 1, the E60A variant poorly complements growth of KLN1, and shows highly reduced activity and about 50fold increased sensitivity to terbinafine and naftifine and 5fold to ketoconazole compared to that in the wild type, and confers temperature-sensitive growth	684491	
1.14.14.17	F203A	site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme	684828